Optimization of a novel series of pyranopyridine RND efflux pump inhibitors

Current Opinion in Microbiology

Volumn 33, Issue , 2016, Pages 1-6

  Aron, Zachary ^a   Opperman, Timothy J ^a  

^a MICROBIOTIX INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; MBX 2319; PYRIDINE DERIVATIVE; UNCLASSIFIED DRUG; ACRAB-TOLC PROTEIN, E COLI; ANTIINFECTIVE AGENT; CARRIER PROTEIN; ESCHERICHIA COLI PROTEIN; MBX2319; PYRAN DERIVATIVE;

DRUG MECHANISM; MULTIDRUG RESISTANCE; NONHUMAN; REVIEW; STRUCTURE ACTIVITY RELATION; ANTAGONISTS AND INHIBITORS; ESCHERICHIA COLI; GENETICS; METABOLISM;

ANTI-BACTERIAL AGENTS; CARRIER PROTEINS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; MEMBRANE TRANSPORT PROTEINS; PYRANS; PYRIDINES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84969786356     PISSN: 13695274     EISSN: 18790364     Source Type: Journal    
DOI: 10.1016/j.mib.2016.05.007     Document Type: Review

References (31)

1. Li X.Z., Plesiat P., Nikaido H. The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria. Clin Microbiol Rev 2015, 28:337-418.
2. Lomovskaya O., Warren M.S., Lee A., Galazzo J., Fronko R., Lee M., Blais J., Cho D., Chamberland S., Renau T., et al. Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy. Antimicrob Agents Chemother 2001, 45:105-116.
3. Renau T.E., Leger R., Filonova L., Flamme E.M., Wang M., Yen R., Madsen D., Griffith D., Chamberland S., Dudley M.N., et al. Conformationally-restricted analogues of efflux pump inhibitors that potentiate the activity of levofloxacin in Pseudomonas aeruginosa. Bioorg Med Chem Lett 2003, 13:2755-2758.
4. Renau T.E., Leger R., Flamme E.M., Sangalang J., She M.W., Yen R., Gannon C.L., Griffith D., Chamberland S., Lomovskaya O., et al. Inhibitors of efflux pumps in Pseudomonas aeruginosa potentiate the activity of the fluoroquinolone antibacterial levofloxacin. J Med Chem 1999, 42:4928-4931.
5. Renau T.E., Leger R., Flamme E.M., She M.W., Gannon C.L., Mathias K.M., Lomovskaya O., Chamberland S., Lee V.J., Ohta T., et al. Addressing the stability of C-capped dipeptide efflux pump inhibitors that potentiate the activity of levofloxacin in Pseudomonas aeruginosa. Bioorg Med Chem Lett 2001, 11:663-667.
6. Renau T.E., Leger R., Yen R., She M.W., Flamme E.M., Sangalang J., Gannon C.L., Chamberland S., Lomovskaya O., Lee V.J. Peptidomimetics of efflux pump inhibitors potentiate the activity of levofloxacin in Pseudomonas aeruginosa. Bioorg Med Chem Lett 2002, 12:763-766.
7. Watkins W.J., Landaverry Y., Leger R., Litman R., Renau T.E., Williams N., Yen R., Zhang J.Z., Chamberland S., Madsen D., et al. The relationship between physicochemical properties, in vitro activity and pharmacokinetic profiles of analogues of diamine-containing efflux pump inhibitors. Bioorg Med Chem Lett 2003, 13:4241-4244.
8. Lomovskaya O., Bostian K.A. Practical applications and feasibility of efflux pump inhibitors in the clinic - a vision for applied use. Biochem Pharmacol 2006, 71:910-918.
9. Nakayama K., Ishida Y., Ohtsuka M., Kawato H., Yoshida K., Yokomizo Y., Hosono S., Ohta T., Hoshino K., Ishida H., et al. MexAB-OprM-specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 1: discovery and early strategies for lead optimization. Bioorg Med Chem Lett 2003, 13:4201-4204.
10. Nakayama K., Ishida Y., Ohtsuka M., Kawato H., Yoshida K., Yokomizo Y., Ohta T., Hoshino K., Otani T., Kurosaka Y., et al. MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 2: achieving activity in vivo through the use of alternative scaffolds. Bioorg Med Chem Lett 2003, 13:4205-4208.
11. Nakayama K., Kawato H., Watanabe J., Ohtsuka M., Yoshida K., Yokomizo Y., Sakamoto A., Kuru N., Ohta T., Hoshino K., et al. MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 3: Optimization of potency in the pyridopyrimidine series through the application of a pharmacophore model. Bioorg Med Chem Lett 2004, 14:475-479.
12. Nakayama K., Kuru N., Ohtsuka M., Yokomizo Y., Sakamoto A., Kawato H., Yoshida K., Ohta T., Hoshino K., Akimoto K., et al. MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 4: Addressing the problem of poor stability due to photoisomerization of an acrylic acid moiety. Bioorg Med Chem Lett 2004, 14:2493-2497.
13. Yoshida K., Nakayama K., Kuru N., Kobayashi S., Ohtsuka M., Takemura M., Hoshino K., Kanda H., Zhang J.Z., Lee V.J., et al. MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 5: Carbon-substituted analogues at the C-2 position. Bioorg Med Chem 2006, 14:1993-2004.
14. Yoshida K., Nakayama K., Ohtsuka M., Kuru N., Yokomizo Y., Sakamoto A., Takemura M., Hoshino K., Kanda H., Nitanai H., et al. MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 7: highly soluble and in vivo active quaternary ammonium analogue D13-9001, a potential preclinical candidate. Bioorg Med Chem 2007, 15:7087-7097.
15. Yoshida K., Nakayama K., Yokomizo Y., Ohtsuka M., Takemura M., Hoshino K., Kanda H., Namba K., Nitanai H., Zhang J.Z., et al. MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 6: exploration of aromatic substituents. Bioorg Med Chem 2006, 14:8506-8518.
16. Yamaguchi A., Nakashima R., Sakurai K. Structural basis of RND-type multidrug exporters. Front Microbiol 2015, 6:327.
17. Nakashima R., Sakurai K., Yamasaki S., Hayashi K., Nagata C., Hoshino K., Onodera Y., Nishino K., Yamaguchi A. Structural basis for the inhibition of bacterial multidrug exporters. Nature 2013, 500:102-106.
18. Inoue Y. SBDD approach of the novel inhibitor of bacterial multidrug efflux transporter. Pacifichem 2015 2015, Honolulu, HI.
19. Opperman T.J., Kwasny S.M., Kim H.S., Nguyen S.T., Houseweart C., D'Souza S., Walker G.C., Peet N.P., Nikaido H., Bowlin T.L. Characterization of a novel pyranopyridine inhibitor of the AcrAB efflux pump of Escherichia coli. Antimicrob Agents Chemother 2014, 58:722-733.
20. Vaara M., Vaara T. Sensitization of Gram-negative bacteria to antibiotics and complement by a nontoxic oligopeptide. Nature 1983, 303:526-528.
21. Nguyen S.T., Kwasny S.M., Ding X., Cardinale S.C., McCarthy C.T., Kim H.S., Nikaido H., Peet N.P., Williams J.D., Bowlin T.L., et al. Structure-activity relationships of a novel pyranopyridine series of Gram-negative bacterial efflux pump inhibitors. Bioorg Med Chem 2015, 23:2024-2034.
22. Sjuts H., Vargiu A.V., Kwasny S.M., Nguyen S.T., Kim H.S., Ding X., Ornik A.R., Ruggerone P., Bowlin T.L., Nikaido H., et al. Molecular basis for inhibition of AcrB multidrug efflux pump by novel and powerful pyranopyridine derivatives. Proc Natl Acad Sci U S A 2016, 113:3509-3514.
23. Murakami S., Nakashima R., Yamashita E., Matsumoto T., Yamaguchi A. Crystal structures of a multidrug transporter reveal a functionally rotating mechanism. Nature 2006, 443:173-179.
24. Seeger M.A., Schiefner A., Eicher T., Verrey F., Diederichs K., Pos K.M. Structural asymmetry of AcrB trimer suggests a peristaltic pump mechanism. Science 2006, 313:1295-1298.
25. Sennhauser G., Amstutz P., Briand C., Storchenegger O., Grutter M.G. Drug export pathway of multidrug exporter AcrB revealed by DARPin inhibitors. PLoS Biol 2007, 5:e7.
26. Eicher T., Seeger M.A., Anselmi C., Zhou W., Brandstatter L., Verrey F., Diederichs K., Faraldo-Gomez J.D., Pos K.M. Coupling of remote alternating-access transport mechanisms for protons and substrates in the multidrug efflux pump AcrB. Elife 2014, 3.
27. Nakashima R., Sakurai K., Yamasaki S., Nishino K., Yamaguchi A. Structures of the multidrug exporter AcrB reveal a proximal multisite drug-binding pocket. Nature 2011, 480:565-569.
28. Seeger M.A., von Ballmoos C., Eicher T., Brandstatter L., Verrey F., Diederichs K., Pos K.M. Engineered disulfide bonds support the functional rotation mechanism of multidrug efflux pump AcrB. Nat Struct Mol Biol 2008, 15:199-205.
29. Pos K.M. Drug transport mechanism of the AcrB efflux pump. Biochim Biophys Acta 2009, 1794:782-793.
30. Su C.C., Li M., Gu R., Takatsuka Y., McDermott G., Nikaido H., Yu E.W. Conformation of the AcrB multidrug efflux pump in mutants of the putative proton relay pathway. J Bacteriol 2006, 188:7290-7296.
31. Vargiu A.V., Ruggerone P., Opperman T.J., Nguyen S.T., Nikaido H. Molecular mechanism of MBX2319 inhibition of Escherichia coli AcrB multidrug efflux pump and comparison with other inhibitors. Antimicrob Agents Chemother 2014, 58:6224-6234.